Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

EGX:RMDA Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	74.96	64.69	52.36	66.96	14	13.23
Short-Term Investments	-	189.7	260.9	361.86	468.01	469.35
Cash & Short-Term Investments	74.96	254.39	313.25	428.82	482.01	482.58
Cash Growth	-75.87%	-18.79%	-26.95%	-11.04%	-0.12%	-6.99%
Accounts Receivable	1,049	791.26	353.74	276.6	265.96	238.41
Other Receivables	61.25	103.43	72.16	22.6	25.2	33.11
Receivables	1,877	1,582	1,344	923.28	684.61	666.63
Inventory	1,200	751.34	303.26	348.41	259.4	305.48
Prepaid Expenses	10.12	4.29	2.21	2.83	0.99	0.91
Other Current Assets	258.67	544.65	60.33	55.14	48.64	40.98
Total Current Assets	3,420	3,137	2,023	1,758	1,476	1,497
Property, Plant & Equipment	728.02	621.52	606.05	556.98	554.99	538.16
Other Intangible Assets	1,094	552.79	589.27	457.57	389.66	214.57
Total Assets	5,242	4,311	3,218	2,773	2,420	2,249
Accounts Payable	346.4	264.36	102.41	120.25	61.53	46.93
Accrued Expenses	140.92	115.09	76.44	62.92	37.31	21.18
Short-Term Debt	2,207	1,555	1,098	910.18	842.6	823.75
Current Portion of Long-Term Debt	-	-	-	-	21.95	58.85
Current Portion of Leases	6	4.48	4.81	3.66	3.13	2.6
Current Income Taxes Payable	88.51	98.78	60.59	53.71	33.49	18.31
Other Current Liabilities	136.78	117.77	30.67	31.23	22.05	18.71
Total Current Liabilities	2,925	2,155	1,373	1,182	1,022	990.33
Long-Term Debt	-	-	-	-	-	29.55
Long-Term Leases	81.59	7.19	11.7	16.34	12.26	14.81
Long-Term Deferred Tax Liabilities	70.52	77.28	58.23	51.56	40.5	31.06
Total Liabilities	3,077	2,240	1,443	1,250	1,075	1,066
Common Stock	377.75	378.23	375	250	250	192.15
Additional Paid-In Capital	316.68	327.51	377.7	397.52	486.97	486.97
Retained Earnings	1,430	1,351	1,022	921.68	610.87	505.79
Treasury Stock	-	-26.23	-26.23	-65.93	-	-
Comprehensive Income & Other	0.28	13.31	14.21	15.31	0.28	0.28
Total Common Equity	2,125	2,044	1,763	1,519	1,348	1,185
Minority Interest	39.88	27.38	12.94	4.59	-2.62	-1.62
Shareholders' Equity	2,165	2,072	1,775	1,523	1,345	1,184
Total Liabilities & Equity	5,242	4,311	3,218	2,773	2,420	2,249
Total Debt	2,294	1,566	1,114	930.18	879.94	929.56
Net Cash (Debt)	-2,219	-1,312	-801.18	-501.37	-397.93	-446.98
Net Cash Per Share	-1.11	-0.66	-0.40	-0.26	-0.20	-0.22
Filing Date Shares Outstanding	2,000	1,990	1,973	1,973	2,015	2,015
Total Common Shares Outstanding	2,000	1,990	1,973	1,956	2,015	2,015
Working Capital	495.1	981.82	650.11	576.53	453.59	506.26
Book Value Per Share	1.06	1.03	0.89	0.78	0.67	0.59
Tangible Book Value	1,031	1,491	1,173	1,061	958.45	970.62
Tangible Book Value Per Share	0.52	0.75	0.59	0.54	0.48	0.48
Land	18.64	18.64	18.64	18.64	18.64	18.64
Buildings	296.8	294.77	288.43	279.17	273.34	257.23
Machinery	683.39	646.31	585.04	533.6	491.55	462.1
Construction In Progress	55.38	33.46	38.09	12.86	27.04	26.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.